EUVIMEDDescoperă EUVIMED
Klinische StudieMultizentrische Studie

Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study

S L Fielding, M A Flower, D Ackery, J T Kemshead, L S Lashford, I Lewis

European Journal of Nuclear Medicine · 1991-05 · 18 (5) · 308-316

DOI: 10.1007/bf02285457 ↗

At a glance

Klinische Studie in European Journal of Nuclear Medicine, 1991-05. Written by S L Fielding and 5 co-authors. Institution: Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK. Major MEDLINE topics: Radiometry. Cited 57 times so far (Crossref); 16 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

In 1987, the United Kingdom Children's Cancer Study Group (UKCCSG) set up a multi-centre study to investigate the toxicity of iodine 131 metaiodobenzylguanidine (mIBG) in the treatment of resistant neuroblastoma. Since December 1987, 25 children suffering from neuroblastoma have been treated with 131I-mIBG at six UK centres. All centres followed standardised physics and clinical protocols to provide consistent toxicity and dosimetry data. These protocols describe the methods employed for both the tracer study using 131I-mIBG and the subsequent therapy. Whole-body dosimetry calculations were performed on data from the tracer study. The activity administered for therapy was the amount predicted to deliver a predefined whole-body dose. Estimates of doses delivered to various organs during treatment are given in Table 1.

Subjects

MeSH terms (MEDLINE)

Radiometry3-IodobenzylguanidineChildChild, PreschoolHumansInfantIodine RadioisotopesIodobenzenesNeuroblastomaRadiotherapy DosageTissue Distribution

Substances

Iodine RadioisotopesIodobenzenes3-Iodobenzylguanidine

Authors and institutions

  • Physics Department, Royal Marsden Hospital, Sutton, Surrey, UK.

Cite

APA

Fielding, S. L., Flower, M. A., Ackery, D., Kemshead, J. T., Lashford, L. S., & Lewis, I. (1991). Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine, 18(5), 308-316. https://doi.org/10.1007/bf02285457

Vancouver

Fielding SL, Flower MA, Ackery D, Kemshead JT, Lashford LS, Lewis I. Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study. European Journal of Nuclear Medicine. 1991;18(5):308-316. doi:10.1007/bf02285457

BibTeX
@article{Fielding1991,
  author = {Fielding, S L and Flower, M A and Ackery, D and Kemshead, J T and Lashford, L S and Lewis, I},
  title = {Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK study},
  journal = {European Journal of Nuclear Medicine},
  year = {1991},
  volume = {18},
  number = {5},
  pages = {308--316},
  doi = {10.1007/bf02285457}
}
Start for free →